$NWBO's spun clinical trial data has many flaws that FDA is

New Post Public Reply Private Reply Replies (0) Message Board
HyGro
1,068
$NWBO's spun clinical trial data has many flaws that FDA is not likely to buy. A recent post on Seeking Alpha provides a good description of the deficiencies in their "new" trial design:
https://seekingalpha.com/news/3836107-nwbo-st...0a%20panel.

Northwest Biotherapeutics Inc. (NWBO) Stock Research Links

NWBO Board Company Profile Buy Rating Time & Sales News Filings Financials